Join
Live feed
·
PRReleasevia Quantisnow
Satsuma Pharmaceuticals Inc. logo

Satsuma Pharmaceuticals Announces Topline Results from SUMMIT Phase 3 Trial of STS101 for the Acute Treatment of Migraine

ByQuantisnow·Wall Street's wire, on your screen.
STSA· Satsuma Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STSA (Satsuma Pharmaceuticals Inc.) and more on Quantisnow.